Skip to main content

The UTS Biologics Innovation Facility (BIF) is an unmatched GMP bioprocessing teaching and training facility, designed to drive opportunities to up-skill and scale-up biopharmaceutical projects using state of the art single-use equipment and industry’s best practice processing techniques.

  • web section

    About the Biologics Innovation Facility

  • 0:20

    [Music playing]


    In this current climate, it’s really important that we have universities and industry collaborating


    really closely on research and development projects.


    GMP Lite is about what we can do in biomaufacturing in general – how we can use life to create


    new products in different kinds of ways, whether it’s through mammalian cell cultures or


    through many other algae cells and so on.


    I think the other dimension that’s really important about GMP Lite is the engagement


    between academia and industry – that is, it’s a facility which is not just about


    university research and university training; it’s about engaging with industry and engaging


    in training industry and using that facility to prototype, to explore, to start to develop


    new products that industry are genuinely engaged in.


    I think GMP in Australia is the first of its kind.


    It is equipped with single-use manufacturing tools, which is kind of like a green way of


    manufacturing going forward, using much less water, much less chemicals, having a much


    lesser carbon footprint compared to the traditional stainless-steel manufacturing system.


    When we talk to industry and government representatives, it becomes clear that we really do have a


    talent gap, a lack of expertise, in that area of the biotech industry and facilities such


    as the GMP will actually provide a means for us to provide that training.


    So in addition to offering education and training to the biologics workforce of the future,


    the GMP Lite facility also is potentially a sandbox for development of processes.


    The value of a sandbox approach is that processes for production can be trialled and refined


    before proceeding to a risky and expensive production run.


    A GMP facility actually gives us focused R&D in this area and how we might be able to scale


    up our manufacturing processes here in Australia and then transfer them to our larger biologic


    manufacturing facilities.


    I think we have been a little bit behind the rest of the world in terms of competitiveness.


    Clinical trials are really that big next step, and good clinical trials.


    Getting that actual last piece of the puzzle that says, ‘yes, we can now help you to


    make your product at the quality you need locally’ is a big step forward.


    So, the biotech space in Australia in 10 years’ time will hopefully be vibrant and will have


    expanded a lot from where it is today, hopefully is broader in terms of the type of drugs that


    are being made and developed and hopefully commercialised and that there’s more of


    an end-to-end business in Australia for biotech.


    The opportunity for Australia and the impact this can have on Australia and the competitiveness


    in really the growth industry of the world, which is Southeast Asia, is here, and there


    really is an opportunity to capture that enormous growth across biologics manufacturing and


    the next generation of human therapeutic manufacturing.


    So, really, this is the time, this is now, and I think Australia, and New South Wales


    in particular, in investing in this, is at the cusp to be able to create our own destiny.

  • A process engineer operating an ÄKTA Ready Gradient Single Use Chromatography system.
  • Global teaching partner with NIBRT

    The NSW node of National Biologics Facility

    Supported by NSW and NCRIS

    Single-use platform technology by GE Healthcare


    Upcoming courses

    UTS/NIBRT: Introduction to Bioprocessing

    Learn more

  • What do we offer?

    Teaching and Training

    BIF provides training in upstream, downstream, and clean room operations. Develop your knowledge and skills through our teaching and training courses.

    Find out more

  • What do we offer?

    Contract Services 

    BIF offers process development, manufacturing, and analytics services for biologics productions. Utilise our facility’s technology and expertise to accelerate your product and research. 

  • A tour group of people in the BIF corridor looking into the facility.

    News and Events

  • BIF is the NSW node of the National Biologics Facility


    Soft infrastructure supported by NCRIS

  • Feature news

    New funding for biologics facility will keep research local

    GlyTherix Ltd has announced that a consortium led by the company are the successful recipients of a competitive grant in Round 9 of the Federal Government’s Cooperative Research Centres Projects.

    Process engineers operating single use upstream bioprocessing equipment.
  • Biologics Innovation Facility
  • Contact us

    For bookings or more information:

    Email us

    Biologics Innovation Facility
    Level 0, UTS Vicki Sara Building (Building 7)
    67 Thomas St
    Broadway, NSW 2007
    University of Technology
    View map